Autolus Therapeutics Cash Flow Statement (2017-2025) | AUTL

Cash Flow Statement Sep2017 Dec2017 Mar2018 Jun2018 Sep2018 Dec2018 Mar2019 Jun2019 Sep2019 Dec2019 Mar2020 Jun2020 Sep2020 Dec2020 Mar2021 Jun2021 Sep2021 Dec2021 Mar2022 Jun2022 Sep2022 Dec2022 Mar2023 Jun2023 Sep2023 Dec2023 Mar2024 Jun2024 Sep2024 Dec2024 Mar2025 Jun2025 Sep2025
Operating Activities
Net Income -0.01B-0.01B0.02B-0.02B-0.03B-0.04B-0.04B-0.02B-0.04B-0.05B-0.05B-0.01B-0.04B-0.05B-0.04B-0.01B-0.04B-0.04B-0.04B-0.03B-0.04B-0.05B-0.05B-0.08B-0.05B-0.06B-0.08B-0.03B-0.07B-0.05B-0.08B
Depreciation and Depletion 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Share-based Compensation 0.01B0.00B0.01B0.01B0.01B0.01B0.00B0.00B-0.00B0.00B0.00B0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.00B0.00B0.00B
Deferred Taxes -0.00B-0.00B0.00B0.00B-0.00B-0.00B-0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.00B-0.00B0.00B-0.00B-0.00B-0.00B-0.00B
Gains from Sales and Divestitures 40,145.62B44,981.86B44,982.38B920.00B107.50B212.50B
Gains from Investment Securities -0.00B0.00B0.03B-0.03B0.00B0.01B0.01B0.03B0.01B-0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Asset Writedowns and Impairment 0.00B0.00B0.00B0.00B0.00B
Non-cash Items 0.00B3,997.66B0.00B5,931.21B5,749.84B6,881.62B6,499.43B6,343.28B
Cash from Operations -0.01B-0.01B-0.03B-0.02B-0.03B-0.02B-0.02B-0.03B-0.04B-0.03B-0.04B-0.04B-0.03B-0.01B-0.04B-0.03B-0.03B-0.01B-0.04B-0.04B-0.04B-0.02B-0.04B-0.05B-0.08B-0.04B-0.08B-0.07B-0.07B
Depreciation, Depletion & Amortization
Amortizatization of Intangibles -0.00B0.00B0.00B0.00B
Depreciation & Amortization (CF) 0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.00B
Change in Working Capital
Change in Receivables 0.01B0.01B0.01B
Change in Inventory 0.00B0.01B0.01B0.01B
Change in Account Payables 0.00B-0.00B0.00B-0.00B0.00B-0.00B-0.00B0.00B-0.00B0.00B0.00B0.00B0.00B0.01B
Change in Accured Expenses 0.00B-0.00B0.02B0.02B0.02B-0.00B0.02B0.03B0.03B-0.00B0.02B0.03B0.02B0.00B0.03B0.00B0.04B0.03B0.03B0.03B
Investing Activities
Change in Net Loans 0.00B-0.00B-0.00B0.00B-0.00B0.00B
Capital Expenditures 0.01B0.00B0.00B0.00B0.02B0.00B0.00B-0.00B0.01B0.00B0.00B-0.00B0.01B0.00B0.00B0.01B0.00B0.00B0.00B0.00B0.00B0.00B0.00B0.01B0.01B0.01B0.01B0.00B
Change in Intangibles 0.00B0.01B
Change in Acquisitions & Divestments 0.02B0.15B0.13B
Cash from Investing Activities -0.00B-0.00B-0.01B-0.00B-0.01B-0.01B-0.00B-0.00B-0.00B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.00B-0.01B-0.38B-0.06B0.10B0.04B
Financing Activities
Other financing activities 0.00B-0.01B0.01B0.01B-0.00B0.00B0.01B0.00B0.00B0.03B0.00B
Debt Issuance and Repayment
Non-Current Debt 0.00B
Net Debt Issuances and Repayments 0.00B
Change in Capital Stock
Shares Issued 0.16B0.00B0.11B0.01B0.07B-0.00B-0.00B0.01B0.13B0.03B0.03B0.11B0.00B0.15B0.00B0.00B0.55B
Misc.
Cash from Financing Activities 0.00B0.16B0.00B0.11B0.00B0.07B-0.00B0.00B0.00B0.12B0.01B-0.00B0.15B-0.00B0.00B0.22B-0.00B-0.00B0.00B0.00B0.56B-0.00B0.00B0.03B-0.00B-0.00B
Exchange Rate Effect 0.00B-0.01B-0.00B-0.01B0.00B-0.01B-0.01B0.02B-0.01B-0.00B0.01B0.01B0.00B0.00B-0.01B0.00B-0.01B-0.02B-0.01B0.01B0.01B0.01B-0.01B0.01B-0.00B0.00B0.04B-0.04B0.00B0.01B-0.00B
Change in Cash 0.11B-0.03B0.22B-0.04B-0.04B-0.05B-0.02B0.52B-0.05B-0.05B-0.43B-0.13B0.03B-0.04B
Beginning Cash Balance 0.14B0.12B0.26B0.14B0.25B0.19B0.27B0.23B0.21B0.24B0.21B0.18B0.15B0.24B0.22B0.17B0.31B0.27B0.22B0.16B0.16B0.38B0.34B0.31B0.26B0.24B0.76B0.71B0.66B0.23B0.10B0.12B
Free Cash Flow -0.01B-0.01B-0.04B-0.02B-0.03B-0.00B-0.02B-0.02B-0.03B-0.03B-0.04B-0.04B-0.04B-0.04B-0.03B-0.02B-0.04B-0.04B-0.04B-0.02B-0.05B-0.04B-0.04B-0.03B-0.04B-0.05B-0.09B-0.05B-0.08B-0.08B-0.07B
Net Cash Flow -0.01B-0.01B0.12B-0.02B-0.03B0.08B-0.00B0.05B-0.03B-0.04B-0.03B0.08B-0.02B-0.04B0.14B-0.04B-0.03B-0.04B0.21B-0.05B-0.04B-0.04B-0.03B0.52B-0.05B-0.09B-0.39B-0.14B0.02B-0.03B